Lilly Announces Webcast to Provide an Overview of Tirzepatide Phase 3 clinical program

Webcast will not include results from any Phase 3 clinical trials INDIANAPOLIS , Nov. 11, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Friday, November 20, 2020 to provide an overview of the tirzepatide Phase 3 type 2 diabetes clinical trial program in